The New A.I. Deal: Buy Everything but the Company
The New York Times
Google, Microsoft and Amazon have made deals with A.I. start-ups for their technology and top employees, but have shied from owning the firms. Here’s why.
In 2022, Noam Shazeer and Daniel De Freitas left their jobs developing artificial intelligence at Google. They said the tech giant moved too slowly. So they created Character.AI, a chatbot start-up, and raised nearly $200 million.
Last week, Mr. Shazeer and Mr. De Freitas announced that they were returning to Google. They had struck a deal to rejoin its A.I. research arm, along with roughly 20 percent of Character.AI’s employees, and provide their start-up’s technology, they said.
But even though Google was getting all that, it was not buying Character.AI.
Instead, Google agreed to pay $3 billion to license the technology, two people with knowledge of the deal said. About $2.5 billion of that sum will then be used to buy out Character.AI’s shareholders, including Mr. Shazeer, who owns 30 percent to 40 percent of the company and stands to net $750 million to $1 billion, the people said. What remains of Character.AI will continue operating without its founders and investors.
The deal was one of several unusual transactions that have recently emerged in Silicon Valley. While big tech companies typically buy start-ups outright, they have turned to a more complicated deal structure for young A.I. companies. It involves licensing the technology and hiring the top employees — effectively swallowing the start-up and its main assets — without becoming the owner of the firm.
These transactions are being driven by the big tech companies’ desire to sidestep regulatory scrutiny while trying to get ahead in A.I., said three people who have been involved in such agreements. Google, Amazon, Meta, Apple and Microsoft are under a magnifying glass from agencies like the Federal Trade Commission over whether they are squashing competition, including by buying start-ups.
The series, “inspired” by the story of a royal dresser later convicted of murder, is getting added attention over the former Duchess of York’s ties to Jeffrey Epstein.
After postponing launch opportunities in February and March, the agency determined that four astronauts could proceed toward the first crewed lunar journey in more than 50 years.
The technology has been used to create misleading fakes before. But never at this scale.
The number doctors use to demarcate hypertension keeps going down, a trend applauded by many experts, who point to studies linking high blood pressure and dementia.
Harry Styles is host and musical guest, while James Austin Johnson and Colin Jost cement their duo as President Trump and his defense secretary on “Saturday Night Live.”
Eleven medical organizations advised changes to preventive cardiac care that it says could markedly reduce heart attacks and strokes.
Two recent deaths tied to for-profit clinics in Canada raised concerns about the health effects of having plasma drawn as often as twice a week.
Amazon, Google and others struck deals in the Persian Gulf to foot the bill for A.I. development. Iran has now threatened attacks against the companies’ infrastructure in the region.
Despite the lack of big names or critical hype, the romance adaptation “Virgin River” has been one of Netflix’s biggest, most reliable successes.
A “red alert” involving the private Blue Ghost mission in lunar orbit a year ago highlights a growing number of incidents above Earth’s neighbor.
The tech giant pushed back the timeline after spending billions to be on the cutting edge of artificial intelligence.
Practitioners nationwide are striving to do what’s best for children’s health, while staying supportive in the face of mistrust and confusion.
A group of scientists and law enforcement officials are pointing to the role moss can play to help solve crimes.